Binder profile
CHEMBL1598306
Bioactivity hit from ChEMBL on a similar protein.
Bound to: PA0552 — phosphoglycerate kinase
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL1598306- UniProt (similar protein)
Q4GZG4- Target protein
- PA0552
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 325.4
- LogP ≤ 5 2.60
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 63.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCOc1ccc(C(C)=O)cc1N1C(=O)C2C3C=CC(C3)C2C1=OCCOc1ccc(C(C)=O)cc1N1C(=O)C2C3C=CC(C3)C2C1=O
InChI=1S/C19H19NO4/c1-3-24-15-7-6-11(10(2)21)9-14(15)20-18(22)16-12-4-5-13(8-12)17(16)19(20)23/h4-7,9,12-13,16-17H,3,8H2,1-2H3InChI=1S/C19H19NO4/c1-3-24-15-7-6-11(10(2)21)9-14(15)20-18(22)16-12-4-5-13(8-12)17(16)19(20)23/h4-7,9,12-13,16-17H,3,8H2,1-2H3
MWCIYVAFULLFFY-UHFFFAOYSA-NMWCIYVAFULLFFY-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Activity
- active
- Binding sites
- PF00162
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL1598306 →
- UniProt UniProt Q4GZG4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL1598306”) →
Other binders for this protein
Quick navigation to other ligands bound to PA0552.
PDB 4
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).